Literature DB >> 21318392

Effects of urinary trypsin inhibitor on lipopolysaccharide-induced acute lung injury in rabbits.

Hong-Beom Bae1, Cheol-Won Jeong, Mei Li, Hyung-Seok Kim, Sang-Hyun Kwak.   

Abstract

This study was undertaken to clarify the effects of urinary trypsin inhibitor (UTI) on lipopolysaccharide (LPS)-induced acute lung injury. Rabbits were randomly assigned to one of seven groups: saline only, UTI, LPS, pre- or post-UTI-high (infusion of UTI of 25,000 U/kg followed by 25,000 U/kg over 2 h), pre- or post-UTI-low (infusion of UTI of 2,500 U/kg followed by 2,500 U/kg over 2 h). UTI was administered 30 min before (pre-groups) or 15 min after (post-groups) LPS administration. Rabbits were mechanically ventilated with 40% oxygen for 6 h. LPS decreased peripheral blood leukocyte counts and increased wet/dry weight ratio of lung, lung injury score, neutrophil infiltration in lung, and IL-8 production in systemic blood and bronchoalveolar lavage fluid (BALF). Rabbits treated by UTI were protected from LPS-induced lung injury, as determined by wet/dry weight ratio, neutrophil infiltration in lung, lung injury score, and IL-8 in BALF levels. UTI attenuated LPS-induced acute lung injury in rabbits mainly by inhibiting neutrophil and IL-8 responses, which may play a central role in sepsis-related lung injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21318392     DOI: 10.1007/s10753-011-9303-y

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  29 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

Review 2.  Clinical developments for treating ARDS.

Authors:  Stephanie Eaton; Greg Martin
Journal:  Expert Opin Investig Drugs       Date:  2002-01       Impact factor: 6.206

3.  Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes.

Authors:  S Aosasa; S Ono; H Mochizuki; H Tsujimoto; C Ueno; A Matsumoto
Journal:  Shock       Date:  2001-02       Impact factor: 3.454

4.  Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B2 production in human monocytes.

Authors:  M Aibiki; J A Cook
Journal:  Crit Care Med       Date:  1997-03       Impact factor: 7.598

5.  The cardiovascular response of normal humans to the administration of endotoxin.

Authors:  A F Suffredini; R E Fromm; M M Parker; M Brenner; J A Kovacs; R A Wesley; J E Parrillo
Journal:  N Engl J Med       Date:  1989-08-03       Impact factor: 91.245

6.  The inhibitory actions of protease inhibitors on the production of polymorphonuclear leukocyte elastase and interleukin 8.

Authors:  S Endo; K Inada; H Yamashita; T Takakuwa; H Nakae; Y Yamada; T Kasai; K Taki; M Yoshida
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1993-10

7.  Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups.

Authors:  S C Donnelly; R M Strieter; S L Kunkel; A Walz; C R Robertson; D C Carter; I S Grant; A J Pollok; C Haslett
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

8.  Neutrophil elastase induces IL-8 synthesis by lung epithelial cells via the mitogen-activated protein kinase pathway.

Authors:  Hao-Cheng Chen; Horng-Chyuan Lin; Chien-Ying Liu; Chun-Hua Wang; Tritium Hwang; Tzu-Ting Huang; Chien-Huang Lin; Han-Pin Kuo
Journal:  J Biomed Sci       Date:  2004 Jan-Feb       Impact factor: 8.410

9.  Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality.

Authors:  E J Miller; A B Cohen; S Nagao; D Griffith; R J Maunder; T R Martin; J P Weiner-Kronish; M Sticherling; E Christophers; M A Matthay
Journal:  Am Rev Respir Dis       Date:  1992-08

10.  Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents.

Authors:  G D Martich; R L Danner; M Ceska; A F Suffredini
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

View more
  12 in total

1.  Urinary trypsin inhibitor attenuated inflammatory response of patients undergoing cardiopulmonary bypass by inducing activated Treg cells.

Authors:  Xing Hao; Junyan Han; Zhichen Xing; Yu Hao; Chunjing Jiang; Jianping Zhang; Jing Yang; Xiaotong Hou
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

2.  The effects of the combination of sodium ferulate and oxymatrine on lipopolysaccharide-induced acute lung injury in mice.

Authors:  Xiaopei Yuan; Yuyun Wang; Dunren Du; Zhao Hu; Mengxin Xu; Mingbo Xu; Zhifeng Liu
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

3.  Urinary trypsin inhibitor attenuates LPS-induced endothelial barrier dysfunction by upregulation of vascular endothelial-cadherin expression.

Authors:  Jie Chen; Jun Wang; Chenglei Su; Wenyi Qian; Li Sun; Hao Sun; Junjie Chen; Huazhong Zhang; Jinsong Zhang
Journal:  Inflamm Res       Date:  2015-12-17       Impact factor: 4.575

4.  Effect of ulinastatin, a human urinary protease inhibitor, on heatstroke-induced apoptosis and inflammatory responses in rats.

Authors:  Zhen Tao; Feng-Qing Hu; Chuan-Fen Li; Tao Zhang; Bing-Zhen Cao; Lian-Qi Cui
Journal:  Exp Ther Med       Date:  2016-11-23       Impact factor: 2.447

5.  Total ginsenosides synergize with ulinastatin against septic acute lung injury and acute respiratory distress syndrome.

Authors:  Rongju Sun; Yana Li; Wei Chen; Fei Zhang; Tanshi Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  Urinary trypsin inhibitor attenuates lipopolysaccharide-induced neutrophil activation.

Authors:  Seong-Heon Lee; Hwi-Jin Kim; Hui-Jing Han; Mei Li; Sang-Hyun Kwak; Sanghee Park
Journal:  Korean J Anesthesiol       Date:  2012-12-14

7.  Effects of ulinastatin administered at different time points on the pathological morphologies of the lung tissues of rats with hyperthermia.

Authors:  Zai-Sheng Qin; Pei Tian; Xia Wu; Hong-Mei Yu; Na Guo
Journal:  Exp Ther Med       Date:  2014-04-01       Impact factor: 2.447

8.  Postconditioning improvement effects of ulinastatin on brain injury following cardiopulmonary resuscitation.

Authors:  Bo Sui; Yongwang Li; Li Ma
Journal:  Exp Ther Med       Date:  2014-08-04       Impact factor: 2.447

9.  Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study.

Authors:  Dilip R Karnad; Rakesh Bhadade; Pradeep K Verma; Nivedita D Moulick; Mradul K Daga; Neelima D Chafekar; Shivakumar Iyer
Journal:  Intensive Care Med       Date:  2014-04-16       Impact factor: 17.440

10.  Ulinastatin attenuates diabetes-induced cardiac dysfunction by the inhibition of inflammation and apoptosis.

Authors:  Wen-Ke Wang; Qing-Hua Lu; Xin Wang; Ben Wang; Juan Wang; Hui-Ping Gong; Lin Wang; Hao Li; Yi-Meng Du
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.